Propionyl-L-Carnitine

DRUG4 trials

Sponsors

Sigma-Tau Research, Inc., sigma-tau i.f.r. S.p.A.

Conditions

Intermittent ClaudicationPeripheral Vascular DiseasesUlcerative Colitis

Phase 2

Propionyl-L-Carnitine in Ulcerative Colitis

CompletedNCT01026857

sigma-tau i.f.r. S.p.A.Ulcerative Colitis

Start: 2006-05-31End: 2009-12-31Updated: 2017-06-15

Phase 3

Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

CompletedNCT00399919

Sigma-Tau Research, Inc.Intermittent Claudication, Peripheral Vascular Diseases

Start: 2006-04-30End: 2008-03-31Updated: 2011-08-25

Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis

TerminatedNCT01538251

sigma-tau i.f.r. S.p.A.Ulcerative Colitis

Start: 2012-04-30End: 2013-12-31Updated: 2016-11-07

Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study

TerminatedNCT01567956

sigma-tau i.f.r. S.p.A.Ulcerative Colitis

Start: 2012-04-30End: 2014-01-31Updated: 2016-11-07